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Summary statement: 
We identify a Hedgehog pathway associated ubiquitin ligase adapter as a direct 
interaction partner of the deubiquitylase USP21 and discover a close interplay 
between USP21 and PKA in regulating Gli1. 
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Abstract  
USP21 is a centrosome-associated deubiquitylase (DUB) that has been implicated in 
the formation of primary cilia, critical organelles for the regulation of the Hedgehog 
(Hh) signaling pathway in vertebrates. Here we identify KCTD6, a Cullin3 E3-ligase 
substrate adapter previously linked to Hh-signaling, as well as Gli1, the key 
transcription factor responsible for Hh signal amplification, as novel interacting 
partners of USP21. We identify a cryptic structured protein interaction domain in 
KCTD6, which is predicted to bear fold similarity to Smr domains. Importantly, we 
show that both depletion and overexpression of catalytically active USP21 suppress 
Gli1-dependent transcription. Gli-proteins are negatively regulated through PKA-
dependent phosphorylation. We provide evidence that USP21 recruits and stabilises 
Gli1 at the centrosome where it promotes its phosphorylation by PKA. By revealing 
an intriguing functional pairing between a spatially restricted DUB and a kinase, our 
study highlights the centrosome as an important hub for signal coordination.  
 
 
INTRODUCTION 
 Hedgehog (Hh) signaling plays an important role during development and has 
also been implicated in diverse malignancies including basal cell carcinomas, 
medullo- and glioblastoma, as well as pancreatic, colon and breast carcinomas 
(Amakye et al., 2013; Takebe et al., 2015). Inhibitors of this pathway are under 
assessment in the clinic as potential anti-cancer therapeutics (Gonnissen et al., 
2015; Takebe et al., 2015). The general architecture of the pathway was initially 
discovered in Drosophila (Nusslein-Volhard and Wieschaus, 1980) but much of the 
cascade is highly conserved from flies to vertebrates (Briscoe and Therond, 2013; 
Ingham et al., 2011). In contrast to many other signaling pathways, Hh signaling is 
constitutively repressed by the interplay of two multi-spanning transmembrane 
proteins, Patched (PTC in Drosophila, PTCH1 and 2 in mammals) and Smoothened 
(SMO). In the absence of a signal, PTC/PTCH1/2 inhibit SMO, and the key 
transcription factors, Ci (Cubitus interruptus) in Drosophila and Gli2/3 in mammals, 
are converted to transcriptional repressors. Gli2/3 are phosphorylated by a series of 
kinases (PKA, CK1, GSK3ß) and in particular Gli3 undergoes processing (limited 
proteolysis) in a phosphorylation, ubiquitylation and proteasome dependent manner 
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to a transcriptionally repressive form. Activation of the pathway is triggered by 
binding of Hh ligands to PTCH1/2, which triggers their endocytosis and leads to de-
repression of SMO favouring activation of Ci/Gli proteins. These translocate into the 
nucleus and activate expression of Hh-responsive genes (Hui and Angers, 2011). In 
mammalian cells, activation of the cascade is localised at the primary cilium, a 
specialised, microtubule based surface organelle. Release of SMO inhibition leads to 
SMO, Gli2 and Gli3 translocation to the cilium and subsequent translocation of the 
unprocessed transcriptionally active Gli proteins to the nucleus. One of the 
transcriptional targets is Gli1, which exclusively functions as an activator of the 
cascade. It is the balance of active and repressive Gli-proteins that determines signal 
strength and outcome. 
 Post-translational modifications play key roles in this cascade (Chen and Jiang, 
2013; Gulino et al., 2012). Reversible ubiquitylation can either promote protein 
degradation or alter subcellular localisation or activity of a protein. Multiple E3-ligases 
are thought to play critical roles in Hh signaling: Cullin1-Slimb/βTrCP, Cullin3-HIB-
Roadkill/SPOP and Itch have all been shown to ubiquitylate and destabilise Gli 
proteins (Jiang, 2006). Approximately 90 deubiquitylases (DUBs) are encoded in the 
human genome (Clague et al., 2013; Komander et al., 2009). This family of enzymes 
has been implicated in the regulation of many canonical signal transduction cascades, 
e.g. NFkB, Wnt, TGFß and the Ras-MAPK pathway (Clague et al., 2012a; Hayes et 
al., 2012; Keusekotten et al., 2013). USP8 has been associated with this cascade in 
Drosophila, where it promotes recycling of SMO (Clague et al., 2012b; Li et al., 2012; 
Xia et al., 2012). However, the role of DUBs in the mammalian Hh signaling pathway 
has only recently been explored (Zhou et al., 2015). 
 We have previously characterised USP21 as the only centrosome and 
microtubule associated DUB in a comprehensive localisation screen (Urbe et al., 
2012). USP21 also associates with basal bodies in ciliated cells and its depletion 
inhibits the formation of primary cilia, which play a critical role in the initiation of Hh 
signaling in vertebrates. Here we identify a novel binding partner of USP21, the BTB-
domain containing, Cullin E3 ligase adapter protein KCTD6 (KCASH3), which has 
previously been implicated in Hh signaling (De Smaele et al., 2011). Importantly, we 
go on to show that either depletion or overexpression of USP21 suppresses Gli1-
dependent transcription in human cells. Our results reveal that USP21 stabilises Gli1 
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at the centrosome and promotes its phosphorylation by PKA, thus contributing to the 
intricate compartmentalisation of the Hh signaling pathway.  
 
RESULTS  
Identification of novel USP21 interacting partners  
We have used a Yeast-two-hybrid (Y2H) approach to search for direct interactors of 
USP21 that may act as substrates or substrate adaptors in the context of 
microtubule- and centrosome-dependent processes. Out of a panel of USP21 
fragments, only those encompassing amino acids [1-174] and [Δ1-47] passed the 
suitability test by failing to auto-activate reporter genes (Materials and Methods, and 
data not shown). We selected USP21 [Δ1-47], which retains all microtubule binding 
and centrosome localisation determinants (Urbe et al., 2012), as a bait to screen a 
universal, normalised human cDNA Y2H library (Fig. 1A). Seven out of ten isolated 
diploid colonies contained plasmids with in-frame annotated coding sequences, two 
of which encode ZNF350 (Zinc finger protein 350). The other proteins identified were 
KCTD6 (BTB/POZ domain-containing protein 6), WDR47 (WD repeat containing 
protein 47), SYNE1 (Spectrin repeat containing, nuclear envelope 1), MPP1 
(Membrane protein, palmitoylated 1, 55kDa) and ANKRD32 (Ankyrin repeat domain 
containing protein 32) (Table 1, Fig. 1A). 
 
USP21 associates with the BTB-domain protein KCTD6  
Two of the six novel USP21 interactors have been shown to localise to microtubule-
based structures. WDR47/Nemitin colocalises with cytoplasmic microtubules via its 
interaction with Microtubule Associated Protein (MAP) 8 (Wang et al., 2012a), whilst 
MPP1 has been localised to the basal body and the ciliary axoneme in murine 
photoreceptors (Gosens et al., 2007). We were particularly intrigued by KCTD6, a 
BTB-domain containing protein that was previously shown to modulate Hedgehog 
signaling in association with the related KCTD11 (De Smaele et al., 2011). We 
validated this interaction by co-immunoprecipitation of epitope-tagged proteins from 
HEK293T cells (Fig. 1B). KCTD6 interacts preferentially with catalytically inactive 
USP21-C221S (USP21CS), which in turn isolates higher molecular weight species of 
mono- and di-ubiquitylated KCTD6 (Fig. 1B,C). USP21CS itself presents as a doublet, 
a phenomenon commonly observed for catalytically inactive mutants of the USP 
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family, e.g. USP4 and USP15, which tend to accumulate as a mono- and poly-
ubiquitylated species (Fig. 1D; (Hayes et al., 2012)). 
 
USP21 interacts with CUL3 via the BTB domain protein KCTD6 
KCTD6 binds to Cullin 3 (CUL3) via its BTB domain, suggesting that it acts as a 
classic substrate adapter of a BTB-CUL3-Rbx1 ubiquitin E3 ligase (De Smaele et al., 
2011; Lange et al., 2012; Smaldone et al., 2015). We wondered whether USP21 
interacts with a fully assembled KCTD6-CUL3 ligase complex. Interactions between 
DUBs and E3 ligases are established in the literature but few examples have been 
analysed in detail (Hayes et al., 2012; Keusekotten et al., 2013; Komander et al., 
2009; Schulein-Volk et al., 2014; Sowa et al., 2009; Villeneuve et al., 2013). Both 
active and inactive USP21 coimmunoprecipitate with CUL3 and vice-versa (Fig. 2B, 
Fig. S1B). Intriguingly, inactive USP21CS enriches a higher molecular weight species 
of CUL3 that could in principle correspond to neddylation, which is required for Cullin-
Ring ligase activation (Bennett et al., 2010). The Nedd8 Activating Enzyme (NAE) 
inhibitor MLN4924 did not affect association of Flag-KCTD6 with endogenous CUL3, 
nor the amount of USP21 bound to KCTD6 (Fig. S1A). Importantly, the supplemental 
CUL3 band was insensitive to MLN4924 suggesting USP21CS promotes the 
stabilisation of ubiquitylated forms of both KCTD6 and CUL3 (Fig. S1B). 
The interaction between USP21 and CUL3 is most likely indirect and mediated 
through KCTD6 as a functional BTB-domain is both required and sufficient (Fig. 
2A,C-D). Two closely related KCTD family members have also been implicated in Hh 
signaling (Canettieri et al., 2010). The KCTD6-interactor KCTD11 (KCASH1/REN), 
but not KCTD21 (KCASH2), binds weakly to wild-type and strongly to catalytically 
inactive USP21 (Fig. S1C). However, in contrast to KCTD6, KCTD11 does not 
appear to be modified in GFP-USP21CS coimmunoprecipitates.  
 
Identification of a cryptic protein interaction domain in KCTD6 
The best-characterised BTB-domain CUL3 adaptors contain defined substrate 
interaction domains such as Kelch, MATH, PHR or zinc fingers (Stogios et al., 2005). 
No such domains have been described for KCTD proteins, yet the region [114-237], 
directly C-terminal of the BTB domain of KCTD6 is sufficient for interaction with 
USP21 (Fig. 3A). The combined results of Y2H and pull-down narrow down the 
USP21 binding site to the [114-187] region of KCTD6 (Fig. 3E). We hypothesized 
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that this region may contain a cryptic protein interacting domain. 
Sensitive bioinformatics tools for detecting distant homologies (HHpred 
(Soding, 2005)) and the Metaserver for fold recognition (Bujnicki et al., 2001) failed to 
identify recognisable relatives of the KCTD6 C-terminal domain. Nevertheless, the 
region is rich in predicted secondary structure, suggestive of a well-folded domain. In 
favourable cases, ab initio modelling can accurately predict the overall fold of a 
queried protein through stitching together fragments of unrelated proteins (Rohl et al., 
2004; Xu and Zhang, 2012). Using this approach, the most promising results were 
obtained for a region comprising residues [109-213], eliminating 24 residues from the 
C-terminus that some methods suggest might be intrinsically disordered. QUARK’s 
favoured model bears a striking resemblance to the C-terminal Smr domain of human 
NEDD4-binding protein 2, with a Z-score of 7.1 for the match, well above the 
threshold of 2 generally taken as indicating significance (PDB code 2vkc (Diercks et 
al., 2008), Fig. 3B, Fig. S1D). According to this model, the C-terminal section [188-
213] of this Smr-like (SmrL) domain, containing a helix and a short ß-hairpin, is 
separate from the remainder of the structure, which thus might be able to fold 
independently. Indeed, separate ab initio modelling efforts with a shorter stretch 
comprising residues [109-187] produced results including structures similar to the 
modelled SmrL domain (not shown). This may account for the observed association 
of USP21 with a C-terminally truncated KCTD6 [114-187] in our Y2H screen.  
Conversely the [Δ1-184] fragment, encompassing the catalytic domain of 
USP21, is necessary and sufficient to bind KCTD6 as well as CUL3 (Fig. 3C,D). 
Taken together, our data indicate that CUL3, KCTD6 and USP21 can form a trimeric 
complex in which the catalytic domain of USP21 interacts with the C-terminal cryptic 
SmrL-domain of KCTD6, whilst the latter’s BTB domain mediates interaction with 
CUL3 (Fig. 3E).  
 
USP21 does not affect KCTD6 and CUL3 protein levels  
Based on previously described interactions between DUBs and E3 ligases, we 
wondered whether USP21 might either stabilise or modulate the activity of the 
KCTD6-CUL3-E3 ligase complex. Neither siRNA mediated depletion, nor 
overexpression of USP21 altered overall CUL3 protein levels or the distribution 
between active (neddylated) and inactive (non-neddylated) forms (Fig. S2A,B). 
Unfortunately, none of the commercially available anti-KCTD6 antibodies we tested 
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recognised endogenous levels of the protein. Flag-KCTD6 protein levels were not 
significantly affected by overexpression of USP21 (Fig. 1B). We conclude that 
despite the enrichment of ubiquitylated KCTD6 and CUL3 in USP21CS 
immunoprecipitates, the stability of either protein is not regulated by USP21. The 
steady state protein levels of the sole known substrate of the previously described 
hetero-dimeric KCTD6-KCTD11 CUL3 E3-Ligase, HDAC1, were also unaffected by 
depletion or overexpression of USP21 (Fig. S2C,D). 
 
USP21 regulates the Hedgehog signaling pathway and modulates Gli1 
transcriptional activity  
KCTD6 has been proposed to act as a negative regulator of the Hh signaling 
pathway (De Smaele et al., 2011). We have previously shown that USP21 depletion 
inhibits the formation of the primary cilium, which also plays a key role in Hh pathway 
activation in non-transformed cells. In order to assess a potential role of USP21 in Hh 
signaling, we first measured Gli1 mRNA levels as a transcriptional readout in NIH3T3 
cells stimulated with a Smoothened agonist (SAG) (Chen et al., 2002). Depletion of 
USP21 inhibits SAG-dependent accumulation of endogenous Gli1 mRNA levels (Fig. 
4A).  
 The main transcriptional activator in the pathway is Gli1 itself, which operates 
via a positive auto-regulatory feedback loop (Hui and Angers, 2011). KCTD6, in 
concert with KCTD11, has previously been shown to target HDAC1 for ubiquitin-
dependent degradation, thereby indirectly modulating the acetylation status and thus 
transcriptional activity of Gli1. With that in mind, we wanted to assess the ability of 
USP21 to affect Gli1 transcriptional activity in the absence of extrinsic pathway 
activation using a Gli1-dependent dual luciferase reporter gene assay. We opted for 
a heterologuous co-expression system of HA-Gli1 and GFP-USP21 in HEK293T cells, 
which permit high levels of transfection efficiency. Importantly, this approach 
introduces constitutively expressed Gli1 together with the Gli1-dependent reporter 
construct into the cells. This allows us to pinpoint the stage at which USP21 may 
regulate Hh signaling, downstream of Smo activation, ie downstream of the already 
established role in primary cilium formation. In this assay, siRNA-mediated depletion 
of USP21 decreased Gli1 transcriptional activity by 39.8 ± 2.7% (Fig. 4B). Likewise, 
overexpression of GFP-USP21 inhibits Gli1 transcriptional activity to a similar degree 
and this inhibition depends on its catalytic activity (Fig. 4C). Altogether these data 
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indicate that USP21 regulates the Hh signaling pathway and either directly or 
indirectly modulates Gli1 transcriptional activity.  
 
USP21 interacts with and stabilises Gli1  
We wondered whether USP21 might regulate the stability of Gli1 and turned to 
CRISPR/CAS9 technology to knock-out USP21 in HEK293T cells, which like many 
cancer cells show autonomous expression of Gli1 (Figure S3A, (Dahmane et al., 
1997; Kinzler et al., 1987; Mazza et al., 2013; Nolan-Stevaux et al., 2009; Tariki et al., 
2014). Transient transfection with plasmids encoding both CAS9-GFP and either one 
of five distinct gRNAs, targeting the second exon encompassing the start codon of all 
annotated USP21 isoforms, resulted in a clear decrease of Gli1 protein levels by 25-
50% (Fig. 5A). Note that in this configuration, residual USP21 derives from non-
transfected cells. Although these results suggest that USP21 stabilises Gli1, the 
observed decrease in endogenous Gli1 could in principle reflect transcriptional 
suppression (see also Fig. 4A).   
We next coexpressed HA-tagged Gli1 together with GFP-USP21 and 
fragments thereof in HEK293T cells. We observed a clear increase in Gli1 protein 
levels in cells co-expressing full-length USP21 (Fig. 5B and S3B). In order to assess 
a potential interaction between these two proteins, we immunoprecipitated HA-Gli1 
and probed for associated GFP-USP21. Full-length GFP-USP21, but not the shortest 
N-terminal fragments [1-120; 1-174], was able to associate with Gli1 (Fig. 5C). Both 
the unstructured N-terminal [1-210] region, required for microtubule and centrosome 
association, and the C-terminal USP21 [∆1-184] region, harbouring the catalytic 
domain, were capable of binding Gli1 independently of each other. Likewise, Flag-
tagged Gli1 and Gli2 were able to co-precipitate Myc-tagged USP21 from HEK293T 
cells (Fig. S3C-D).  
 Having shown above that the catalytic domain of USP21 also interacts with 
the KCTD6-CUL3 E3-ligase complex, we wondered whether KCTD6 would be able to 
influence Gli1 stability in this setting. Co-expression of KCTD6 with USP21 
counteracts its ability to stabilise Gli1 (Fig. 5D). This suggests the direct interaction of 
KCTD6 with the USP21 catalytic domain disrupts its regulation of Gli1. 
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USP21 stabilises a phosphorylated form of Gli1 
The increase of Gli1 protein levels upon USP21 overexpression appears to be at 
odds with the observed inhibition of Gli1-transcriptional activity in this setting (Fig. 
4C). On close inspection, we observed a higher molecular weight form of Gli1 in 
USP21 overexpressing cells, indicative of a post-translational modification (Fig. 6A). 
This band was significantly reduced in cells coexpressing catalytically inactive 
USP21CS, and absent in cells expressing truncated versions of USP21 (Fig. S3B). 
Many components of the Hh signaling pathway are regulated by acetylation, 
phosphorylation, ubiquitylation and sumoylation (Chen and Jiang, 2013; Gulino et al., 
2012). In particular, Gli transcriptional activity is regulated by several kinases, thus 
we assessed whether USP21 induces Gli1 phosphorylation. Incubation of 
immunoprecipitated HA-Gli1 with Calf Intestinal Alkaline Phosphatase (CIP) induced  
the disappearance of the upper band that is only present in cells overexpressing full-
length USP21 (Fig. 6B).  
Phosphorylation of Gli transcription factors can either activate or inhibit their 
transcriptional activity. In the absence of pathway activation, sequential 
phosphorylation of Gli3, and to a lesser extent Gli2, by PKA, CKI and GSK3β induces 
ubiquitin-dependent limited proteolysis to generate a transcriptionally repressive form, 
GliR (Briscoe and Therond, 2013; Hui and Angers, 2011). Phosphorylation by PKA 
alone leads to Gli2/3 inactivation (Niewiadomski et al., 2014; Tuson et al., 2011) and 
has been proposed to inhibit nuclear localisation of Gli1 (Sheng et al., 2006). Finally, 
phosphorylation of Gli1 by S6K1 in response to mTOR activation triggers its release 
from the repressor SuFu leading to its transcriptional activation (Wang et al., 2012b). 
Guided by our functional experiments indicating an inhibitory role of USP21 
expression on Gli1-dependent transcription (Fig. 4C), we focused on PKA-dependent 
phosphorylation as a potential target of USP21. Co-expression of PKI, a well-
established PKA-inhibitor (Scott et al., 1985), abolished the USP21-induced 
accumulation of phosphorylated Gli1 (Fig. 6C). Strikingly, the decrease of Gli1 
phosphorylation is concomitant with a decrease in its protein levels, suggesting that 
USP21 induced phosphorylation of Gli1 is coupled with its stabilisation (Fig. 6C). 
Similarly, a pool of Gli2 appears stabilised in a PKI-sensitive manner by co-
expression of USP21 (Figure S3C-D and S4A). Altogether these data indicate that 
USP21 stabilises inactive Gli1 and promotes its phosphorylation by PKA.  
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USP21 promotes Gli1 localisation at the centrosome 
How then could the deubiquitylase USP21 induce Gli1 phosphorylation by PKA? We 
have previously reported that USP21 is most highly enriched at the centrosome and 
basal body of ciliated cells (Urbe et al., 2012). PKA has previously been shown to be 
enriched and active at these two locations (Nigg et al., 1985; Terrin et al., 2012; 
Tuson et al., 2011). U2OS cells allow ready discrimination of intracellular structures 
due to their planar geometry and expanded cytoplasm. In these cells, endogenous 
PKA colocalises with GFP-USP21 at the centrosome (Fig. 6D). Neither wild-type or 
catalytically inactive USP21 affect PKA protein levels (Fig. S4B). Given that full 
stabilisation of phosphorylated Gli1 requires the USP21 N-terminal microtubule and 
centrosome targeting sequence, we wondered whether USP21 influences the 
localisation of Gli1. Expressed on its own, HA-Gli1 presents with a diffuse, 
cytoplasmic and nucleoplasmic staining. However, co-expression of either wild-type 
or catalytically inactive GFP-USP21 strongly promotes its recruitment to the 
centrosome (Fig. 6E). 
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DISCUSSION  
 
USP21 interacts with KCTD6, a CUL3 substrate adapter via its catalytic domain 
 Our genome wide Y2H screen has yielded six novel interactors of USP21. The 
fact that WDR47 and MPP1 have been shown to associate with microtubules or the 
basal body and axoneme, respectively, makes these likely candidates for future 
studies (Gosens et al., 2007; Wang et al., 2012a). Here, we have focused exclusively 
on KCTD6, a CUL3-binding BTB protein that has previously been implicated in the 
Hh signaling pathway. This pathway is of particular interest to USP21 function, due to 
its prominent association with centrosomes, basal bodies, microtubules and primary 
cilia. We have mapped this interaction to the catalytic domain of USP21 and a novel 
cryptic protein interaction domain, here called Smr-like (SmrL) that is unique to 
KCTD6. The Smr domain is generally associated with nuclease function (Fukui et al., 
2007). However the KCTD6-SmrL does not bear the positively charged surface of the 
NEDD4BP2 Smr structure characteristic of DNA/RNA binding proteins, nor a suitably 
positioned catalytic Glu residue (Zhang et al., 2014). Browsing the SCOP structure 
classification database (Andreeva et al., 2008) at the fold level containing Smr 
domains reveals a second theme of protein-protein interaction, exemplified by 
bacterial sulphurtransferase TusA (Shi et al., 2010) and the predicted dimeric form of 
NEDD4BP2 (according to the PISA resource (Krissinel and Henrick, 2007)). This is 
clearly consistent with the protein-protein interaction role determined here for the 
KCTD6 C-terminal domain and supported by existing precedents of the same fold 
serving both DNA- and protein-binding functions (cf zinc fingers (Matthews and 
Sunde, 2002)). The novel SmrL domain is restricted to KCTD6, although KCTD11 
and 21 may harbor their own distinct cryptic domains adjacent to the BTB. KCTD11, 
but not KCTD21, has been shown to hetero-dimerise with KCTD6, providing a 
possible explanation for its interaction with USP21 in pull-down experiments. USP21, 
unlike many other members of the USP family, does not contain insertions in its 
catalytic domain that may encode additional protein interaction motifs or domains. 
Thus, KCTD6 is the first protein besides Ubiquitin (and ISG15 (Ye et al., 2011)) that 
interacts with the catalytic core of USP21, and a rare example of a core binding 
protein considering the USP family as a whole.  
 What then is the role of this interaction? E3-ligase DUB interactions can 
protect the ligases from autoubiquitylation (e.g. MDM2 stabilisation by USP7 
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(Cummins and Vogelstein, 2004), BRAP/IMP stabilisation by USP15 (Hayes et al., 
2012)). Alternatively they may limit the levels of the respective DUBs or exert fine 
control over a common substrate. We have not found evidence that USP21 and 
KCTD6 affect each other’s stability, nor does USP21 affect global CUL3 stability or 
neddylation status. However, the fact that co-expression of catalytically inactive 
USP21 results in the accumulation of minor mono- and di-ubiquitylated species of 
KCTD6 and CUL3, indicates the potential for USP21 to modulate their ubiquitylation 
status. Alternatively, USP21 may be acting directly to deubiquitylate the substrates of 
the Cullin Ring Ligase, in an analogous fashion to USP28, which associates with the 
CUL1-adapter FBW7 to deubiquitylate a range of substrates including MYC 
(Schulein-Volk et al., 2014). In contrast to FBW7, we have very little knowledge of the 
substrates targeted by KCTD6. The closely related BTB-proteins KCTD11 and 
KCTD21 undergo hetero and homo-dimerisation to target HDAC1 for CUL3-
dependent ubiquitylation and degradation (Canettieri et al., 2010). Degradation of 
HDAC1 promotes the accumulation of transcriptionally inactive, acetylated Gli1. De 
Smaele and colleagues reported that KCTD6, despite lacking a binding site for 
HDAC1, could dimerise with its paralogues KCTD11 (but not KCTD21) and 
contribute to HDAC1 ubiquitylation and degradation (De Smaele et al., 2011). Whilst 
we cannot exclude that USP21 directly stabilises KCTD6 substrates, we have not 
observed any global effects on HDAC1 protein levels in response to siRNA mediated 
depletion or overexpression of USP21.  
 
USP21, a novel regulator of the Hh signaling pathway 
 Our results suggest that endogenous USP21 positively regulates Hh signaling 
by two independent mechanisms: Firstly, we have previously shown that USP21 
depletion interferes with the formation of primary cilia, the specialised organelles that 
host the initiation of the Hh signaling cascade in untransformed mammalian cells 
(Goetz and Anderson, 2010; Urbe et al., 2012). Secondly, we now show that 
depletion of USP21 not only inhibits SAG-induced transcription in ciliated NIH3T3 
cells but also directly interferes with Gli1-dependent activation of a Gli-promoter 
driven luciferase reporter in Gli1-transfected HEK293T cells. AlthoughHEK293T cells 
have previously been shown to be capable of generating primary cilia (Gerdes et al., 
2007; Lancaster et al., 2011), under the conditions of our assay (48 hrs in 0.5% FBS) 
only 30% of cells do so. Whilst we cannot exclude that some aspects of exogenous 
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Gli1-activation may rely on primary cilium formation, taken together our data showing 
1) an interaction between USP21 and Gli1, 2) the regulation of PKA dependent 
phosphorylation of Gli1 by USP21, and 3) the colocalisation of all three proteins at 
the centrosome in U2OS cells make a strong case for a regulatory role of USP21 that 
may be independent of cilium formation. 
This positions USP21 downstream of SMO and PTCH, and highlights its potential as 
a new drug target to counteract Hh signaling. This may be of particular relevance in 
tumours expressing aberrant levels of Gli1 or that are otherwise activated 
downstream of PTCH and thus resistant to the SMO-inhibitor Vismodegib (Amakye et 
al., 2013). In this context it is interesting to note that USP21 has been identified in a 
large-scale screen as one of only few genes with a significantly increased copy 
number count in breast tumour samples (Kan et al., 2010). The fact that both 
depletion and overexpression of USP21 interfere with Gli1-dependent transcription 
suggests that appropriate USP21 protein levels are key to ensure optimal Hh 
signaling outputs. 
 
Dual role of USP21 in stabilising phosphorylated Gli1 at the centrosome 
 Intriguingly, overexpression of USP21 represses Gli1-dependent transcription 
despite the fact that the total amount of Gli1 is clearly increased. Associated with this, 
we observe the accumulation of a phosphorylated pool of Gli1 in USP21 
overexpressing cells. Whilst we have not identified the phosphorylation sites in this 
study, we provide evidence for the kinase involved in this modification. PKA has 
recently been shown to phosphorylate multiple serines that are conserved in all Gli-
proteins and to suppress Gli-activity in the absence of a Hh signal (Niewiadomski et 
al., 2014). Our results suggest that USP21 overexpression facilitates these 
phosphorylation events by recruiting Gli1 either directly or indirectly to the 
centrosome, which harbours active PKA (Terrin et al., 2012). In ciliated cells, USP21 
is localized at the centrosome-derived basal body, where PKA is thought to act on Gli 
proteins travelling to and from the cilium (Tuson et al., 2011). USP21 may thus 
promote coincidence of substrate and kinase at these locations. Our data suggest 
that expression levels of USP21 need to be tightly regulated as both its depletion and 
overexpression can hamper Hh signaling. However, the role of USP21 exceeds that 
of an adapter, since both localisation determinants and catalytic activity are required 
for maximal stabilisation of phosphorylated Gli1 (Fig. 5B and Fig. S3A). It is 
 15	
conceivable that USP21 regulates both the phosphorylation status and the stability of 
Gli1 (and possibly Gli2) at the centrosome (Fig. 6F). Our finding provides a unique 
illustration of the close interplay of a DUB and a kinase at this location and supports 
the concept of centrosomes functioning as intracellular signaling hubs/scaffolds 
(Arquint et al., 2014).   
 A recent report has identified USP7 as a DUB that is able to stabilise Gli2/3 by 
opposing both Ubiquitin E3-ligase complexes involved in processing or degradation 
of Gli2/3 in the absence or presence of Hh, SCF(ßTRCP) (Slmb/Cul1) and Itch 
(HIB/CUL3) respectively (Zhou et al., 2015). Our results suggest a more complex 
scenario in which the restricted localisation of USP21 facilitates the accumulation of 
an inactive pool of Gli1 at the centrosome. Extending this model to the basal body 
provides a means of orchestrating Gli protein activity upon entry into or exit from the 
primary cilium.  
 
MATERIALS AND METHODS 
 
Yeast-two-hybrid - The coding sequences for USP21[Δ1-47] was subcloned from 
pCR4-TOPO-USP21[Δ1-47] into the pGBKT7 vector (Clontech). The resultant 
pGBKT7-USP21[∆1-47] plasmid was sequenced-verified and transformed into 
Y2HGold yeast cells. Single colonies that failed to autonomously activate the reporter 
genes in the absence of prey proteins on -Tryptophan/X-alpha-Gal plates, -
Tryptophan/X-alpha-Gal/AureobasidinA plates and -Tryptophan/-Adenine/-
Histidine/X-alpha-Gal/AureobasidinA plates were selected for the mating procedure. 
Briefly, Y2HGold pGBKT7-USP21[Δ1-47] cells were incubated with the human 
normalised cDNA Y187 prey library (Clontech) in 2YPAD for 23h at 30°C. More than 
2.4x106 diploid clones were screened and selected for 5 days on SD/-Trp/-Leu/X-α-
Gal/Aba. 20 clones were picked and streaked onto SD/-Trp/-Leu/-His/-Ade/X-α-
Gal/Aba plates for 7 days. Interacting proteins were identified by yeast colony PCR 
and subsequently by sequencing of the extracted plasmid.  
 
Cell culture and transfection – U2OS, HEK293T and NIH3T3 cells were cultured in 
Dulbecco’s modified Eagle medium (DMEM) with Glutamax (Gibco, Carlsbac, CA). 
Media were supplemented with 10% FBS, 1% nonessential amino acids solution, and 
1% penicillin/streptomycin. All cell lines are routinely tested for mycoplasma 
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contaminations. Transfections of plasmids in HEK293T and U2OS cells were 
performed with Genejuice (Novagen). For the dual luciferase reporter assays 
(Promega), plasmids were transfected with lipofectamine 2000 (Invitrogen) into 
HEK293T cells (DMEM, 0.5%FBS). Cells were fixed or lysed 24h after transfection. 
For siRNA experiments, cells were treated with non-targeting (NT3) or target specific 
siRNA oligos (Dharmacon On Target Plus oligos, Thermo Fisher Scientific; 
Supplementary Table 1) at 40nM final concentration, once or twice over a period of 
96h (HEK293T) or 120h (U2OS). NIH3T3 cells were treated at 12nM final 
concentration, twice over a period of 120h. All siRNA experiments were performed 
using RNAiMAX (Invitrogen). For Hh pathway activation, the NIH3T3 cells were first 
serum starved in DMEM with Glutamax for 24h, prior to addition of 100nM SAG or 
DMSO for 4h.  
 
Quantitative reverse transcription-PCR (RT-PCR) - Cells were lysed and mRNA 
extracted using the RNAeasy mini kit (Qiagen). cDNA synthesis was performed using 
1µg RNA with RevertAid H-minus M-MuLV reverse transcriptase (Fermentas) using 
an oligo-dT primer (Promega). Quantitative real-time RT-PCR was performed in 
triplicate using iTaq Universal SYBR Green Supermix and a CFX Connect Real-Time 
PCR detection machine (Bio-Rad). Primer sequences are listed in the Supplementary 
table 2. 
 
Co-immunoprecipitation - HEK293T cells were transfected with a total of 2.4µg of 
DNA per 1x106 cells. 24h after transfection, the cells were washed in cold phosphate-
buffered saline (PBS) and lysed in RIPA-lysis buffer (10mM Tris-HCl pH7.5, 150mM 
NaCl, 1% NP40, 0.1% SDS, 1% sodium deoxycholate) or in NP40-lysis buffer (0.5% 
NP40, 25mM Tris-HCl pH7.5, 100mM NaCl, 50mM NaF) supplemented with 10mM 
N-Ethylmaleimide and mammalian protease inhibitor (Sigma) and phosphatase 
inhibitor cocktails (Roche). Lysates were incubated with primary antibodies and 
protein G or protein A-agarose beads (P4691 and P2670, Sigma) or with anti-FLAG 
M2 Affinity Gel (Sigma, A2220) for 1h at 4°C. Beads were washed with RIPA or YP-
IP buffer (0.1% NP40, 25mM Tris pH7.5 and 150mM NaCl) 3-5 times and once with 
10mM Tris pH7.5. Immunoprecipitated samples and 10µg of the input were 
evaluated by western blotting.  
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Western blot analysis - Cultured cells were lysed with RIPA or NP40-lysis buffers 
(see above). Proteins were resolved by SDS PAGE (Invitrogen NuPage gel 4-12%), 
transferred to nitrocellulose and probed with primary antibodies over night. For anti-
ubiquitin antibodies, membranes were boiled 30min in distilled water and then 
blocked with 0.5% FISH gelatin in TBST. Otherwise blocking and antibody solutions 
contained 5% milk. Visualisation and quantitation of western blots was carried out 
using an Odyssey infrared scanner (LI-COR Biosciences, Lincoln, NE).  
 
Antibodies, Plasmids and Reagents - Antibody sources were as follows: anti-
USP21 (Sigma, HPA028397), anti-Gli1 (clone L42B10, Biolabs, 2643S), anti-CUL3 
(Bethyl, A301-109A), anti-ubiquitin (clone P4G7, Covance, MMS-258R), anti-HA 
(clone 16B12, Covance, MMS-101P), Polyclonal anti-Flag (Sigma, F7425), 
Monoclonal anti-Flag (clone M2, Sigma, F3165), anti-GFP and anti-RFP (sheep and 
rabbit respectively, gift of Ian Prior), anti-beta-actin (Abcam, ab6276), anti-Pericentrin 
(Abcam, ab4448), anti-PKAC (BD BioSciences, 610980).HDAC1 antibody was 
obtained from Santa-Cruz (sc-6298), and anti-Myc from Millipore (clone 4A6, 05-724). 
MLN4924 was obtained from Millenium Pharmaceuticals. 
Cloning primer sequences used in this work are shown in Supplementary Table 3. 
pCXN2-Flag-KCTD6, pCMV-3HA-Gli1 (G933D), pGLB3B-12Gli-Luc and pRL-Renilla-
TK plasmids were previously described (Canettieri et al., 2010; De Smaele et al., 
2011). KCTD6 was amplified from a liver cDNA library, inserted into pCR4-TOPO 
(Invitrogen), and subcloned into pCMV-Tag2B-Flag vector. KCTD6 [114-237] was 
amplified from pCR4-TOPO-KCTD6, inserted into pET151 vector and subcloned into 
pCMV-Tag2B-Flag vector. pGFP-GW, pGFP-GW-USP21, pGFP-GW-USP21CS, 
pGFP-C1-USP21[1-174], pGFP-C1-USP21[1-210], pGFP-C1-USP21[Δ1-47], pGFP-
C1-USP21[Δ1-121] and pGFP-USP21[Δ1-184] plasmids were previously described 
(Urbe et al., 2012). pCDNA4-CUL3-[1-250]-Flag and pCDNA4-CUL3-H2x5 H5x2 
[L52A, E55A, Y58A, R59A, Y62A, Y125A and R128A] plasmids were kindly provided 
by Michael Rape (University of California, Berkeley, USA). Myc, Myc-USP21 and 
Myc-USP21CS plasmids were previously described (Urbe et al., 2012). pCXN2-Flag-
KCTD11, pCXN2-Flag-KCTD21 and pCDNA-Flag-Gli1 have previously been used in 
(Canettieri et al., 2010; De Smaele et al., 2011). Murine Gli2 cDNA was kindly 
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provided by Hiroshi Sasaki and sub-cloned by means of BamHI-NotI restriction 
digestion in a pCDNA3-vector engineered to contain an in-frame 5' flag sequence. 
CRISPR plasmids expressing Cas9-GFP from a CMV promoter and selected gRNAs 
from a U6 promoter were kindly provided by Horizon Discoveries, Ltd (Cambridge, 
UK). The gRNAs used were designed to target the second exon of USP21 gene, 
encompassing the start codon (Supplementary Table 4). PKI-Cherry plasmid was 
kindly provided by Oliver Rocks (Max Delbrück Center for Molecular Medicine, Berlin). 
Smoothened Agonist (SAG, CAS 364590-63-6) was purchased from Calbiochem.  
 
Dephosphorylation Assay - Cells were lysed in NP40-lysis buffer supplemented 
with 10mM NEM, mammalian protease and phosphatase inhibitors. Lysates (500µg) 
were incubated with Protein G-beads and HA antibody for 1h at 4°C. Beads were 
washed 3 times with YP-IP buffer, and once with 1X CutSmart buffer (NEB). Beads 
were resuspended in 40µl CutSmart buffer and 3µl Calf Intestinal Alkaline 
Phosphatase, (CIP, NEB), incubated for 1h at 30°C and the reaction was stopped by 
adding 5mM of EDTA and subsequent incubation at 65°C for 30min. Equivalent 
reaction volumes were loaded on a gel and evaluated by western-blot.  
 
Modelling the C-terminal domain of KCTD6 - Possible distant homology of the C-
terminal domain of KCTD6 with known domains or structures was assessed using 
HHpred (Soding, 2005) and the META-server (Bujnicki et al., 2001). Ab initio 
modelling was done with ROSETTA (Rohl et al., 2004) or QUARK (Xu and Zhang, 
2012). QUARK returns 10 ranked fold predictions derived from clustering of ab initio 
models. Likewise, ten candidate structure predictions were derived from 1000 ab 
initio models using the clustering algorithm of the ROSETTA suite. Structural 
similarity of predictions to known folds was assessed with DALI (Holm and Sander, 
1993) and the classifications of proteins of interest in the SCOP database (Andreeva 
et al., 2008) consulted.  
 
Immunofluorescence - Cells on coverslips were rinsed once with PBS, fixed at -
20°C with Methanol, blocked in 10% goat serum, and incubated with primary and 
secondary antibodies in 5% goat serum (1h each), all in PBS. Secondary antibody 
was conjugated to Alexa Fluor 594 or 355. Immunofluorescence images were taken 
using a 3i Spinning Disk microscope (63x Oil objective) and a digital camera 
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(Hamatsu, CMOS). The images were then processed using SlideBook software and 
Photoshop CS4 Version 11.0 (Adobe). Pearson’s correlation coefficients were 
calculated using Coloc2 Plugin on Fiji.  
 
Statistics - P values are indicated as *P,0.05, **P,0.01 and ***P,0.001 and derived 
either by two tailed paired t-test or, for multiple comparison analysis, by one-way 
ANOVA and Dunnett’s post-hoc test using GraphPad Prism6. 
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FIGURE LEGENDS 
 
Figure 1: USP21 interacts with KCTD6, a component of the BTB-CUL3-Rbx1 
Ubiquitin E3 ligase complex  
(A) A Y2H screen of a normalised human cDNA library using USP21 [∆1-47] as a bait 
identifies the CUL3-substrate-adapter protein KCTD6 [1-187]. USP, ubiquitin specific 
protease; BTB, Broad-Complex, Tramtrack and Bric a brac. A Smr-like domain 
(SmrL) was identified by ab initio modeling (see Figure 3). 
(B) Validation of the interaction of USP21 with KCTD6 in human cells. HEK293T cells 
were transfected with Flag-KCTD6 and either GFP, GFP-USP21 or GFP-USP21CS. 
Lysates were subjected to immunoprecipitation with GFP or Flag antibodies.  
(C) Inactive USP21 co-precipitates ubiquitylated KCTD6. Lysates were used for 
immunoprecipitation with anti-GFP antibody. Interacting proteins were analysed by 
western blot with anti-Flag and anti-Ubiquitin (P4G7) antibodies. Exp: exposure 
(B, C) Arrowheads indicate mono- (<) and di-(<<)ubiquitylated species of KCTD6. 
Arrow indicates unmodified KCTD6. 
(D) The higher molecular weight form of USP21-C221S (arrow) corresponds to a 
mono-ubiquitylated species. Lysates from the experiment shown in C were subjected 
to immune-precipitation with anti-GFP antibodies and probed in parallel with anti-
Ubiquitin or anti-GFP antibodies. 
 
Figure 2: Indirect interaction of USP21 with Cullin 3 
(A) Diagram of the featured CUL3 constructs: Full-length CUL3, a BTB-domain 
binding mutant (CUL3m) and a dominant negative C-terminal truncation mutant 
(CUL3 [1-250]). Asterisks indicate point mutations. 
(B) USP21 interacts with CUL3 in HEK293T cells. HEK293T cells were transfected 
as indicated and lysates subjected to immunoprecipitation with GFP and Flag 
antibodies respectively. Asterisk indicates a higher molecular weight form of Flag-
CUL3. 
(C,D) HEK293T cells were cotransfected with USP21 and with either CUL3m (C) or 
with CUL3 [1-250] (D). Protein lysates were subjected to immunoprecipitation with 
anti-GFP or anti-Flag. The interacting proteins were analysed by western blot with 
anti-GFP and either anti-CUL3 or anti-Flag. 
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Figure 3: Mapping the interaction between USP21 and KCTD6-CUL3 E3 Ligase 
complex 
(A) USP21 interacts with KCTD6 [114-237]. HEK293T cells were transfected with 
Full-length (FL) or truncated KCTD6, GFP or GFP-USP21, and IPs were performed 
and analysed as indicated. 
(B) The overall fold similarity between the favoured QUARK ab initio model of the 
KCTD6 Smr-like domain (SmrL [109-213]) and the C-terminal Smr domain of human 
NEDD4-binding protein 2 (PDB code 2vkc;1400 Diercks,T. 2008). Each is coloured in 
a spectrum from blue (N-terminus) to red (C-terminus). A broken line indicates the 
boundary between the functionally dispensable C-terminal region [188-213] and the 
remainder.  
(C,D) HEK293T cells transfected with Flag-KCTD6 (C) or Flag-CUL3 (D) and GFP-
tagged USP21 fragments were lysed in RIPA buffer. Protein lysates were used for IP 
with GFP antibody. Asterisk indicates a mono-ubiquitylated form of Flag-KCTD6. 
(E) Diagram summarising the interactions between USP21 and KCTD6 and CUL3, 
components of the BTB-Cullin3-Rbx1 E3 Ligase complex. USP21[Δ1-184] is both 
necessary and sufficient for the interaction with KCTD6 [114-187]. Cullins share a 
homologous C-terminus that interacts with the Ring-finger protein Rbx1.  
 
Figure 4: USP21 modulates Hedgehog signaling and Gli1 transcriptional 
activity 
(A) NIH3T3 cells were treated with USP21-targeting siRNA oligos (#10, 11, 12) or a 
non-targeting control (NT3), serum starved and then incubated with SAG (100nM) for 
4h prior to mRNA extraction. USP21 and Gli1 mRNA levels were measured by qRT-
PCR and normalised to RNA Pol2 (n=3 independent experiments, ±SD).  
(B) HEK293T cells were treated with USP21-targeting siRNA-oligos (#5, #6) or non-
targeting control oligo (NT3), or treated with transfection reagent alone (Mock). 24 
hours before lysis, cells were transfected with Gli-responsive firefly luciferase and 
Renilla luciferase reporters (pGLB3B-12Gli-Luc and pRL-Renilla-TK) as well as with 
a Gli1 expression construct (HA-Gli1). Efficiency of the knockdown was assessed by 
western-blotting. (n=2, bar=range)  
(C) HEK293T cells were transfected with Gli-responsive firefly luciferase, Renilla 
luciferase reporters, 3HA-Gli1 and indicated amounts of GFP, GFP-USP21 or GFP-
USP21CS plasmids. GFP-protein expression was assessed by western-blotting. 
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(GFP: n=5; USP21/CS: n=6, ±SD,	one-way ANOVA and Dunnett’s test) 
 
Figure 5: USP21 regulates Gli1 expression levels 
(A) USP21 knockout results in a decrease in endogenous Gli1 protein. HEK293T 
cells were transfected with plasmids encoding both Cas9-GFP and one of 5 
independent CRISPR gRNAs targeting USP21. Cells were lysed in RIPA lysis buffer 
72h after transfection. Protein lysates were assessed by western-blot (representative 
experiment). Arrow indicates the major USP21 isoform (63kDa) (Okuda et al., 2013). 
The scatter plot illustrates the close correlation between USP21 and Gli1 protein 
levels across conditions. Pink and blue dots indicate Mock and USP21 gRNA 
respectively. 
(B) USP21 overexpression increases Gli1 protein levels. HEK293T cells were 
cotransfected with indicated plasmids. Protein lysates were evaluated by western-
blot.  
(C) USP21 interacts with Gli1. Lysates shown in (B) were subjected to 
immunoprecipitation with HA antibody. 
(D) KCTD6 counteracts USP21 dependent Gli1 stabilisation. HEK293T cells were 
transfected with HA-Gli1 and GFP-USP21 and increasing amount of Flag-KCTD6. 
Protein lysates were assessed by western-blot. (n=3; ±SD; one-way ANOVA and 
Dunnett’s test).  
 
Figure 6: USP21 recruits Gli1 to the centrosome and promotes its 
phosphorylation by PKA. 
(A) HEK293T were transfected with indicated plasmids for 24h. Protein expression 
was assessed by western-blotting with HA and GFP antibodies. Graph shows the 
quantitation of the upper form of HA-Gli1 (n=3, ±SEM, one-way ANOVA and 
Dunnett’s test).  
(B) HEK293T were lysed 24h after transfection with the indicated plasmids, 
immunoprecipitated HA-Gli1 was incubated with Alkaline Phosphatase (CIP) at 30°C 
for 1h. Red arrowheads (<) indicate the upper phosphorylated band. 
(C) HEK293T were transfected with HA-Gli1, GFP or GFP-USP21 and increasing 
amounts (µg) of PKI-Cherry or RFP control. Cells were lysed 24h after transfection. 
Protein levels were assessed by western-blotting with HA and RFP antibodies and 
membranes were reprobed with anti-GFP. 
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(D) USP21 colocalises with the catalytic subunit of PKA (PKAC) at centrosomes. 
U2OS cells were transfected with GFP-USP21 or GFP alone as a control. After 
MeOH fixation, cells were stained with anti-PKAC (red) and anti-Pericentrin (blue) 
antibodies. Images were captured with a 3i Spinning Disk confocal microscope (63x 
objective).  
(E) USP21 and Gli1 colocalize at the centrosome. U2OS cells were co-transfected 
with HA-Gli1 and GFP-USP21 or GFP-USP21CS. After MeOH fixation, cells were 
stained with Gli1 (red) and Pericentrin (blue) antibodies. Images were captured with a 
3i Spinning Disk (63x objective). Pearson correlation coefficients for Gli1 or GFP 
colocalisation with Pericentrin were calculated on ≥33 cells per condition. Scale bar = 
10µm. 
(F) Working model illustrating the dual role of USP21 in regulating Gli1. USP21 
recruits Gli1 at the centrosome and thereby promotes consequential phosphorylation 
by PKA. PKA may act as a priming kinase for further phosphorylation and 
ubiquitylation events. Wild-type but not catalytically inactive USP21 is able to 
stabilise the labile pool of phosphorylated Gli1.   
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Clone Protein Name Gene ID Region Interacting with 
USP21[Δ1-47] (aa) 
#1 BTB/POZ domain-containing protein KCTD6 200845 1-187 
#2 WD repeat containing protein 47 WDR47 22911 685-927 
#3 Spectrin repeat containing, nuclear envelope 1 SYNE1 23345 2940-3140 
#4 Zinc finger protein 350 ZNF350 59348 292-530 
#5 Zinc finger protein 350 ZNF350 59348 291-415 
#6 Membrane protein, palmitoylated 1, 55kDa MPP1 4354 318-466 
#7 Ankyrin repeat domain containing protein 32 ANKRD32 84250 802-1058 
 
Table 1: Identification of potential interacting proteins of USP21 by Yeast-two-Hybrid 
using a Human normalised library. Seven clones encoding six new candidate 
interactors for USP21 were isolated from a Human normalized prey cDNA library 
using an USP21-bait construct encoding aa 48-565. Abbreviations: aa, amino-acids  
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SUPPLEMENTAL Tables:   
 
Supplementary Table 1: siRNA oligos (DHARMACON Thermoscientific) 
siRNA names Gene 
ID 
Catalog 
number 
Sequence 
Hs USP21 
siRNA#5 
27005 J-006071-05 CCACCCACUUUGAGACGUA 
Hs USP21 
siRNA#6 
27005 J-006071-06 GAUCCAAGCUACCAUUUGC 
Hs USP21 
siRNA#7 
27005 J-006071-07 CGAGAGCCACCUGUUAAUA 
Hs USP21 
siRNA#8 
27005 J-006071-08 CUUCGGGACUUCUGUCUGA 
Hs Gli1 siRNA (On 
Target Plus Pool) 
2735 L-003896-00 GCAAAUAGGGCUUCACAUA 
AGGCUCAGCUUGUGUGUAA 
GGACGAGGGACCUUGCAUU 
CAGCUAGAGUCCAGAGGUU 
Mm USP21 
siRNA#10 
30941 J-063216-10 ACUUAAUGUGGAAGCGCUA 
Mm USP21 
siRNA#11 
30941 J-063216-11 UACAAUGACUCCCGCGUUU 
Mm USP21 
siRNA#12 
30941 J-063216-12 CUUCCUGAAUGCCGUGCUA 
NT1 
 
D-001810-01 UGGUUUACAUGUCGACUAA 
NT3 
 
D-001810-03 UGGUUUACAUGUUUUCUGA 
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Supplementary Table 2: QPCR Primers  
Target Primer Name Primer Sequence 
Gli1 
Gli1_Mm_Forward CCA GCA GCT GCA CTG AAG GAT C 
Gli1_Mm_Reverse CCA GCT CTG ACT TCA GCT GG 
USP21 
USP21_Mm_Forward CTG ATG ACA AGA TGG CTC ACC AC 
USP21_Mm_Reverse CCA ATC ACA TCT GCA AAG GCT TCT 
G 
POL2 
POL2_Mm_Forward CCGGAAGCTTACCATGGAAC 
POL2_Mm_Reverse TGTCTGTCTGAGGTAAGTGC 
 
Supplementary Table 3: Cloning Primers 
Target Primer Name Primer Sequence 
KCTD6 
KCTD6_lib-Forward CT GGG CTC TTG AAG ACG C 
KCTD6_lib-Reverse GGA GAG TCT TTC CAG GAA CC 
KCTD6_aa114-Forward CATATGatggatacttttgaagaagttgtgg 
KCTD6_aa237_Reverse GTCGACtcagtcgtctgtcttccgggctagcctacag 
MPP1 
MPP1_lib- Forward GTCTTGCGTTCCAGTGTTCC 
MPP1_ lib-Reverse AGTGGGTTCCCCCATTCTAC 
 
Supplementary Table 4: USP21 CRISPR gRNA  
gRNA name Guide 
id 
Sequence 
USP21gRNA#2 47002 GCATTGTGGACACCACAGGC 
USP21gRNA#3 47003 CAGGCGGTGCTCAGAGGCCT 
USP21gRNA#4 47004 TAACAGGTGGCTCTCGGGTA 
USP21gRNA#5 47005 GGTAGCTTGGATCCCACTCG 
USP21gRNA#6 47006 CTCCTTGCTGCGGGCCCTGG 
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Supplementary Figure 1:  
(A) The substrate adaptor KCTD6 interacts with neddylated and de-neddylated CUL3. 
HEK293T were transfected with GFP-USP21 and Flag-KCTD6 and then incubated with 
1µM of MLN4924 or DMSO for 4h. Protein lysates were used for IP with Flag antibody.  
(B) Interaction of USP21 with CUL3 is not affected by MLN4924 treatment. HEK293T were 
transfected with the indicated plasmids for 24h and then incubated with 1µM MLN4924 or 
DMSO for 4h before being lysed and subjected to IP. Asterisks indicate higher molecular 
weight forms of CUL3. 
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(C) USP21 interacts with KCTD11 but not KCTD21. HEK293T cells were transfected with 
Flag-KCTD11 or Flag-KCTD21 together with GFP, GFP-USP21 or GFP-USP21-C221S 
(CS). Protein lysates were subjected to immunoprecipitation with GFP antibody. 
(D) Structure alignment of favoured QUARK ab initio model of KCTD6 [109-213] and the 
C-terminal Smr domain of human NEDD4-binding protein 2 (PDB code 2vkc;1400 
Diercks,T. 2008). The alignment results from a DALI database search and achieved a Z-
score of 7.1. Jalview was used to display the alignment and to annotate regular secondary 
structure elements seen in model and NMR structure (red α-helices; green β-strands) 
(Waterhouse, A. M. et al., 2009 Bioinformatics 25, 1189-91). 
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Supplementary Figure 2:  
(A,B) CUL3 protein level and neddylation are not regulated by USP21. U2OS cells were 
transfected either with USP21 siRNA oligos (A) or with GFP, GFP-USP21 or GFP-
USP21CS (B). CUL3 protein levels were assessed by western-blotting with a CUL3 
specific antibody. 
(C,D) USP21 does not regulate HDAC1 protein level. U2OS cells were transfected either 
with USP21 siRNA oligos (C) or with GFP-USP21CS (D). Endogenous HDAC1 was 
assessed by western-blot. 
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Supplementary Figure 3: USP21 promotes Gli1 stabilisation and interacts with Gli1 
and Gli2. 
(A) HEK293T cells express low levels of endogenous Gli1. HEK293T cells were treated for 
96 hours with siRNA targeting Gli1 (siGli1p, On Target Plus pool), lysed and proteins were 
subjected to western blot analysis. 
Heride et al. Supplemental 
	   5 
(B) USP21 overexpression induces Gli1 stabilisation. HEK293T cells were cotransfected 
with indicated plasmids. Protein lysates were evaluated by western-blot. 
(C and D) HEK29T cells were co-transfected with Myc-USP21 (USP21) or an empty Myc-
vector (Myc) and Flag-Gli1 or -Gli2 or an empty Flag-vector (Flag). Cells were lysed in 
NP40-lysis buffer and subjected to immunoprecipitation with anti Flag M2 affinity gel (C) or 
anti-Myc antibody (D), followed by western blotting with indicated antibodies.   
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Supplementary Figure 4: USP21 promotes Gli1 and Gli2 phosphorylation by PKAC 
without affecting PKAC expression levels. 
(A) USP21 promotes Gli2 phosphorylation by PKAC. HEK293T were transfected with Flag-
Gli1 or Flag-Gli2, GFP or GFP-USP21 and increasing amounts (µg) of PKI-Cherry or RFP 
control plasmids. Cells were lysed 24h after transfection. Samples were assessed by 
western-blotting with Flag and RFP antibodies and membranes reprobed with anti-GFP. 
High exp. : high exposure. 
(B) USP21 overexpression does not affect PKA protein levels. HEK293T cells were 
transfected with indicated plasmids. Protein lysates were evaluated by western-blot.   
